Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NADPH oxidase 4 (NOX4) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the NOX4 transcript that governs the stability and translation of the NOX4 enzyme. Unlike other NOX isoforms, NOX4 is constitutively active and primarily regulated at the transcriptional and post-transcriptional levels, making its mRNA 3'UTR a key site for controlling cellular reactive oxygen species (ROS) production [PMID: 22319247]. This region contains multiple conserved binding sites for microRNAs, such as miR-25 and miR-146a, which act as endogenous suppressors of NOX4 expression to maintain redox homeostasis [PMID: 23912945, PMID: 28652424]. In pathological states like idiopathic pulmonary fibrosis and diabetic nephropathy, the regulation of the NOX4 3'UTR is often disrupted, leading to enzyme overexpression, excessive hydrogen peroxide production, and subsequent tissue damage and fibrosis [PMID: 25100643]. Targeting the NOX4 mRNA 3'UTR with antisense oligonucleotides or microRNA mimics represents a precise therapeutic strategy to downregulate NOX4 protein levels and mitigate oxidative stress-driven diseases. Such approaches aim to overcome the limitations of small-molecule inhibitors by providing higher specificity for the NOX4 isoform over other NADPH oxidases.
Therapeutic agents target the NOX4 mRNA 3'UTR to modulate protein expression through RNA interference (RNAi), antisense-mediated degradation (RNase H recruitment), or by blocking/mimicking microRNA binding sites to alter mRNA stability and translation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH oxidase 4 mRNA 3' untranslated region (NOX4 mRNA 3'UTR) (NOX4 mRNA 3'UTR).